121 related articles for article (PubMed ID: 11163021)
1. Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia.
Hoffmann MM; Scharnagl H; Köster W; Winkler K; Wieland H; März W
Clin Chim Acta; 2001 Jan; 303(1-2):41-8. PubMed ID: 11163021
[TBL] [Abstract][Full Text] [Related]
2. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
[TBL] [Abstract][Full Text] [Related]
3. Compound heterozygote for both rare apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) and E3(Cys112-->Arg, Arg251-->Gly) alleles in a multigeneration pedigree with hyperlipoproteinaemia.
Richard P; Beucler I; Pascual De Zulueta M; Biteau N; De Gennes JL; Iron A
Clin Sci (Lond); 1997 Jul; 93(1):89-95. PubMed ID: 9279208
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
März W; Hoffmann MM; Scharnagl H; Fisher E; Chen M; Nauck M; Feussner G; Wieland H
J Lipid Res; 1998 Mar; 39(3):658-69. PubMed ID: 9548597
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
Wardell MR; Rall SC; Brennan SO; Nye ER; George PM; Janus ED; Weisgraber KH
J Lipid Res; 1990 Mar; 31(3):535-43. PubMed ID: 2341812
[TBL] [Abstract][Full Text] [Related]
7. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.
Hoffmann MM; Scharnagl H; Panagiotou E; Banghard WT; Wieland H; März W
J Am Soc Nephrol; 2001 Mar; 12(3):524-530. PubMed ID: 11181800
[TBL] [Abstract][Full Text] [Related]
8. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
Horie Y; Fazio S; Westerlund JR; Weisgraber KH; Rall SC
J Biol Chem; 1992 Jan; 267(3):1962-8. PubMed ID: 1730728
[TBL] [Abstract][Full Text] [Related]
9. Heterozygosity for apolipoprotein E-4Philadelphia(Glu13----Lys, Arg145----Cys) is associated with incomplete dominance of type III hyperlipoproteinemia.
Lohse P; Rader DJ; Brewer HB
J Biol Chem; 1992 Jul; 267(19):13642-6. PubMed ID: 1352296
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.
Lohse P; Mann WA; Stein EA; Brewer HB
J Biol Chem; 1991 Jun; 266(16):10479-84. PubMed ID: 1674745
[TBL] [Abstract][Full Text] [Related]
11. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
Mann WA; Gregg RE; Sprecher DL; Brewer HB
Biochim Biophys Acta; 1989 Oct; 1005(3):239-44. PubMed ID: 2804053
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia.
Hidaka H; Tozuka M; Hidaka E; Yamauchi K; Ota H; Honda T; Katsuyama T
Ann Clin Lab Sci; 2001 Apr; 31(2):163-70. PubMed ID: 11337906
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease.
Kang AK; Jenkins DJ; Wolever TM; Huff MW; Maguire GF; Connelly PW; Hegele RA
Mutat Res; 1997 Sep; 382(1-2):57-65. PubMed ID: 9360638
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.
Minnich A; Weisgraber KH; Newhouse Y; Dong LM; Fortin LJ; Tremblay M; Davignon J
J Lipid Res; 1995 Jan; 36(1):57-66. PubMed ID: 7706948
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of type III hyperlipoproteinemia in Germany.
Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W
Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433
[TBL] [Abstract][Full Text] [Related]
17. The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance.
de Villiers WJ; van der Westhuyzen DR; Coetzee GA; Henderson HE; Marais AD
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):865-72. PubMed ID: 9157949
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
Rall SC; Weisgraber KH; Innerarity TL; Mahley RW
Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4696-700. PubMed ID: 6289314
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
Gregg RE; Ghiselli G; Brewer HB
J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein profiles in a family with two mutants of apolipoprotein E: possible association with hypertriglyceridaemia but not with dysbetalipoproteinaemia.
Zhao SP; Van den Maagdenberg AM; Vroom TF; Van 't Hooft FM; Gevers Leuvens JA; Havekes LM; Frants RR; Van der Laarse A; Smelt AH
Clin Sci (Lond); 1994 Mar; 86(3):323-9. PubMed ID: 8156744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
